Summary
The Ninth Circuit affirmed the district court's grant of summary judgment in favor of Doctor's Best on a claim for declaratory judgment of non-infringement and a counterclaim for trademark infringement under the Lanham Act. Applying the Supreme Court's framework in Abitron, the panel held that the Lanham Act's trademark provisions are not extraterritorial and limited its analysis to the defendant's domestic conduct, which consisted solely of manufacturing and transporting supplements for exclusive sale abroad. Utilizing the Sleekcraft factors, the court concluded there was no genuine issue of material fact regarding a likelihood of consumer confusion, as the parties operated in entirely separate marketing channels and the defendant had no realistic plans to expand into the U.S. market.
Topics
Practice areas
Questions Presented
- Whether the district court properly applied Abitron Austria GmbH v. Hetronic International, Inc. to identify the domestic conduct actionable under the Lanham Act when the products were manufactured and transported in the United States but sold and marketed exclusively abroad.
- Whether the evidence created a genuine issue of material fact regarding a likelihood of consumer confusion from Doctor's Best's domestic transport of Nature's Day products.
- Whether the district court abused its discretion by denying Nature's Way's Federal Rule of Civil Procedure 56(d) motion for additional discovery before ruling on summary judgment.
Holdings
- Under Abitron, the Lanham Act's trademark-infringement provisions apply only where the claimed infringing use in commerce is domestic. Transporting goods bearing the mark in the United States qualifies as domestic use in commerce under 15 U.S.C. § 1127, so Nature's Way's claim was within the territorial scope of the Lanham Act to that extent.
- The district court properly granted summary judgment because no reasonable jury could find a likelihood of consumer confusion from Doctor's Best's domestic transport of Nature's Day products.
- The district court did not abuse its discretion in denying Nature's Way's Rule 56(d) motion and deciding summary judgment before the scheduled close of discovery.
Key quotations
“The likelihood of confusion element of a trademark infringement claim existed before Abitron, see § 1127, and remains intact after, subject to the limitation that the confusion-causing conduct must occur domestically.” (11)
“Only a domestic use in commerce causing a likelihood of confusion is within the scope of the Lanham Act’s trademark infringement provisions.” (13)
“Therefore, although the marks are hypothetically confusable, the likelihood of consumer confusion, given the existing record, is nonexistent, because the marks do not appear in the same marketplace.” (20)
Factual background
Nature's Way Products owned the U.S. trademark "Nature's Way" for nutritional supplements. Doctor's Best developed "Nature's Day" supplements, manufactured them in California, and transported them through the United States for sale and marketing exclusively to consumers in China, South Korea, and Taiwan. Doctor's Best did not sell or market the Nature's Day products to U.S. consumers, and the record showed no overlapping U.S. marketing channels or strong possibility of expansion into the U.S. market.
Procedural history
After receiving Nature's Way's cease-and-desist letter, Doctor's Best filed an action seeking a declaratory judgment of non-infringement. Nature's Way counterclaimed for trademark infringement and related claims. The district court denied Nature's Way's Rule 56(d) motion, granted summary judgment to Doctor's Best, and entered judgment in its favor. The Ninth Circuit affirmed.